Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Unlock the potential of using credit card points to book travel deals. Make the most of your rewards for a fantastic travel experience.
19,974 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Investing in space-related stocks can be thrilling and risky. This article lays out two crucial things every rocket i...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
SDNY prosecutors seek a new trial for Tornado Cash co-founder Roman Storm in October 2026, even as U.S. agencies ackn...
Coinbase and Bybit are in early-stage talks about a strategic investment partnership that could pave the way for Bybi...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
Memes have evolved from jokes into a serious branding engine. In 2026, chuck norris never dies: anchors licensing dea...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Celcuity stock popped today after the company released its 2025 results, showing a tighter quarterly loss despite no ...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...